Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149,315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing the application of mNGS after combined pneumonia in hematologic patients receiving hematopoietic stem cell transplantation and chemotherapy: A retrospective analysis.
Zhang B, Gui R, Wang Q, Jiao X, Li Z, Wang J, Han L, Zhou L, Wang H, Wang X, Fan X, Lyu X, Song Y, Zhou J. Zhang B, et al. Among authors: wang h, wang x, wang j, wang q. Front Cell Infect Microbiol. 2022 Sep 21;12:969126. doi: 10.3389/fcimb.2022.969126. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36211959 Free PMC article.
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial.
Zu Y, Li Z, Gui R, Liu Y, Zhang Y, Yu F, Zhao H, Fu Y, Zhan X, Wang Z, Xing P, Wang X, Wang H, Zhou J, Song Y. Zu Y, et al. Among authors: wang x, wang h, wang z. Bone Marrow Transplant. 2022 Oct;57(10):1573-1580. doi: 10.1038/s41409-022-01754-y. Epub 2022 Jul 15. Bone Marrow Transplant. 2022. PMID: 35840747 Free PMC article. Clinical Trial.
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial.
Zu Y, Gui R, Li Z, Wang J, Zhang Y, Yu F, Zhao H, Zhan X, Wang Z, Xing P, Wang X, Wang H, Song Y, Zhou J. Zu Y, et al. Among authors: wang x, wang h, wang j, wang z. Blood Cancer J. 2023 Jan 11;13(1):10. doi: 10.1038/s41408-022-00771-w. Blood Cancer J. 2023. PMID: 36631450 Free PMC article. Clinical Trial. No abstract available.
149,315 results
You have reached the last available page of results. Please see the User Guide for more information.